AXIM Biotechnologies Ratios and Metrics

Market cap in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	Current	FY 2023	FY 2022	FY 2021	FY 2020	FY 2019	2018 - 2014
Period Ending	Mar '26 Mar 6, 2026	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021	Dec '20 Dec 31, 2020	Dec '19 Dec 31, 2019	2018 - 2014
Market Capitalization	5	5	5	60	54	23	Upgrade
Market Cap Growth	391.06%	-12.57%	-91.35%	10.19%	135.52%	-48.38%	Upgrade
Enterprise Value	-	10	11	66	59	29	Upgrade
Last Close Price	0.01	0.02	0.03	0.43	0.43	0.36	Upgrade
PS Ratio	49.25	114.26	581.91	987.63	-	-	Upgrade
PB Ratio	-0.48	-0.59	-1.07	-25.54	34.61	-3.40	Upgrade
EV/Sales Ratio	-	260.76	1201.77	1086.71	-	-	Upgrade
Debt / Equity Ratio	-0.71	-0.77	-1.18	-2.89	4.05	-0.75	Upgrade
Net Debt / Equity Ratio	-0.71	-0.75	-1.17	-2.69	3.75	-0.65	Upgrade
Net Debt / EBITDA Ratio	-3.60	-2.47	-1.33	-1.07	-1.19	-1.41	Upgrade
Net Debt / FCF Ratio	-8.89	-5.57	-2.75	-2.49	-1.77	-0.87	Upgrade
Asset Turnover	0.02	0.01	0.00	0.01	-	-	Upgrade
Quick Ratio	0.00	0.03	0.01	0.18	0.31	0.21	Upgrade
Current Ratio	0.00	0.03	0.03	0.25	0.48	0.48	Upgrade
Return on Assets (ROA)	-36.27%	-41.26%	-60.99%	-60.17%	-47.56%	-102.77%	Upgrade
Return on Capital Employed (ROCE)	81.30%	148.10%	-567.70%	-292.00%	-50.40%	182.50%	Upgrade
Earnings Yield	-90.39%	-178.50%	-120.88%	-26.85%	-11.83%	-28.02%	Upgrade
FCF Yield	-16.65%	-22.82%	-39.75%	-4.23%	-6.11%	-21.90%	Upgrade
Buyback Yield / Dilution	-27.42%	-37.60%	-25.79%	-19.16%	-78.19%	-8.14%	Upgrade

Source: S&P Capital IQ. Standard template. Financial Sources.